4//SEC Filing
Horne William E 4
Accession 0001493152-21-010086
CIK 0001591165other
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 8:39 PM ET
Size
8.8 KB
Accession
0001493152-21-010086
Insider Transaction Report
Form 4
H-CYTE, INC.HCYT
Horne William E
DirectorChief Executive Officer
Transactions
- Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+3,655,382$51,175→ 3,655,382 total(indirect: SEE FOOTNOTE)From: 2020-09-24→ COMMON STOCK (3,655,382 underlying) - Other
STOCK PURCHASE WARRANTS
2020-09-24+1,869,667→ 1,869,667 total(indirect: SEE FOOTNOTE)Exercise: $0.01From: 2020-09-24→ COMMON STOCK (1,869,667 underlying)
Footnotes (5)
- [F1]Received upon conversion of variable conversion price notes at closing of Qualified Financing. Conversion price became fixed at such closing. Series A stock is convertible into common stock on a 1:1 basis.
- [F2]Pursuant to a registered rights offering on September 11, 2020, the Company issued 10,966,145 shares of its Series A Preferred Stock and 5,609,002 warrants to Uyona Management II, LLC. The reporting person has 1/3 ownership of Uyona Management II, LLC. While the rights offering expired on September 11, 2020, it was not consummated until September 24, 2020.
- [F3]Redeemable at option of requisite number of holders in specified circumstances.
- [F4]Received in connection with variable conversion price notes. No additional consideration was paid for warrants. Exercise price became fixed at closing of Qualified Financing.
- [F5]Not applicable.
Documents
Issuer
H-CYTE, INC.
CIK 0001591165
Entity typeother
Related Parties
1- filerCIK 0001788406
Filing Metadata
- Form type
- 4
- Filed
- Apr 28, 8:00 PM ET
- Accepted
- Apr 29, 8:39 PM ET
- Size
- 8.8 KB